New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
08:02 EDTMASIMasimo says CFD study shows SET Pulse Oximetry as effective tool
Masimo announced that the largest-ever study of newborn screening for congenital heart disease, or CHD, was published online by The Lancet. The study of 122,738 newborns -- more than twice as large as any previous study of this type -- was conducted using Masimo SET Measure-through Motion and Low Perfusion Pulse Oximetry and showed that Masimo SET pulse oximetry screening significantly increased the rate of CHD detection and is "feasible and reliable" for detecting major congenital heart disease. Congenital heart defects are a leading cause of infant death in high-income countries, and affect eight of 1,000 livebirths. Critical congenital heart disease, or CCHD, defined as causing death or requiring invasive intervention in the neonatal period, occurs in one to two newborns per 1,000 livebirths. Without CCHD detection and intervention, serious injury or death is common.
News For MASI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
16:49 EDTMASIMasimo narrows 2014 EPS view to $1.28 from $1.24-$1.30, consensus $1.24
Subscribe for More Information
16:47 EDTMASIMasimo reports Q3 EPS 27c, consensus 25c
Subscribe for More Information
October 23, 2014
08:21 EDTMASIMasimo says Arkansas Heart Hospital using SET pulse oximetry
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use